Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing‐remitting multiple sclerosis
Lenka Novakova; Markus Axelsson; Mohsen Khademi; Henrik Zetterberg; Kaj Blennow; Clas Malmeström; Fredrik Piehl; Tomas Olsson; Jan Lycke
Author Information: Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy
Checking for direct PDF access through Ovid |
Abstract
Abstract unavailable for this article.